Novel polypeptide, and composition for skin care and hair growth promotion, comprising same as active ingredient
A novel polypeptide with specific amino acid sequences addresses the limitations of existing materials by enhancing skin elasticity and collagen synthesis, and promoting hair growth, providing a stable and effective solution for skin aging and hair loss prevention.
Patent Information
- Application Number
- PCT/KR2026/005641
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-13
- Filing Date
- 2026-04-27
- Publication Date
- 2026-11-19
AI Technical Summary
Existing materials for skin aging improvement and hair growth promotion often lack stability, limited skin penetration, and have concerns regarding cost and side effects, with rare instances of a single ingredient achieving both cosmetic and therapeutic actions effectively.
A novel polypeptide with specific amino acid sequences, such as KAAAADNIIDFLKDD, RAAATDNIIDFLKDD, RAATTDNIIDFLKDD, RTADADNIIDFLKDN, and RATDADNIIDFLKDN, is developed to enhance skin elasticity and collagen synthesis while promoting hair growth and preventing hair loss, with high hydrophilicity and solubility.
The polypeptide effectively prevents skin aging, improves wrinkles, enhances skin flexibility and elasticity, and promotes hair growth by inducing fibroblast and dermal papilla cell proliferation, offering a multi-targeting solution with improved stability and solubility.
Smart Images

Figure KR2026005641_19112026_PF_FP_ABST
Abstract
Description
Novel polypeptide and a composition for skin care and hair growth promotion containing the same as an active ingredient
[0001] This application claims priority to Korean Patent Application No. 10-2025-0061982 filed on May 13, 2025, and the entire specification thereof is a reference to this application. The present invention relates to a novel polypeptide and a composition for skin care and hair growth promotion comprising the same as an active ingredient, and more specifically, to a polypeptide having an amino acid sequence expressed as (N-terminus) - X1X2X3X4X5D NIIDFLKD X6- (C-terminus), wherein X1 to X6 are each independently, X1 is lysine (K) or arginine (R); X2, X3, and X5 are each alanine (A) or threonine (T); X4 is alanine (A), threonine (T), or aspartic acid (D); X6 relates to a polypeptide that is aspartic acid (D) or asparagine (N); and a composition for improving wrinkles, enhancing skin flexibility, enhancing skin elasticity, preventing skin aging, preventing hair loss, and promoting hair growth, comprising these polypeptides as active ingredients.
[0002]
[0003] In modern society, along with interest in appearance, the demand for skin health, anti-aging, and hair health is steadily increasing. In particular, skin aging is accelerated not only by increasing age but also by various external factors such as ultraviolet rays, environmental pollution, and stress; its main characteristics include wrinkle formation, decreased skin elasticity, and dryness. Fibroblasts, which exist in the dermis layer of the skin, play a key role in maintaining skin elasticity and structure by participating in the biosynthesis of major matrix proteins such as collagen and elastin. Among these, collagen, a fibrous protein that accounts for 70% of the dermis, performs functions such as the mechanical firmness (elasticity) of the skin, resistance of connective tissue and tissue cohesion, support for cell adhesion, and induction of cell division and differentiation.
[0004] However, as aging progresses, the number and activity of fibroblasts decline, and the resulting decrease in collagen synthesis ability leads to aging phenomena such as wrinkles and loss of elasticity. Therefore, the development of substances capable of promoting fibroblast proliferation or inducing collagen synthesis is considered one of the major challenges in the fields of cosmetics and pharmaceuticals for improving and preventing skin aging.
[0005] Meanwhile, as hair health is a crucial aesthetic and psychological factor, interest in preventing hair loss and promoting hair growth is increasing. Dermal papilla cells (DPCs), which are one of the constituent cells of the hair follicle, play a vital role in hair growth and maintenance. These cells are involved in the hair root growth cycle and hair production; a decline in the proliferation and activity of DPCs can shorten the hair growth cycle and accelerate hair loss. Therefore, increasing the proliferation or survival rate of DPCs can promote hair growth and prevent hair loss.
[0006] Various attempts have been made to improve skin aging, reduce wrinkles, and prevent hair loss or promote hair growth. For instance, various ingredients such as Vitamin C, retinoids, peptides, and natural extracts have been used as materials to promote skin collagen synthesis and improve wrinkles, while drugs like minoxidil and finasteride have been commercialized as anti-hair loss agents and hair growth promoters. Recently, research utilizing bioactive substances such as growth factors, cytokines, and specific peptides has been actively conducted; however, various limitations exist, including the lack of stability of existing materials, limited skin penetration, and concerns regarding cost and side effects. In particular, it is very rare for a single ingredient to simultaneously exhibit skin aging improvement and hair growth effects, and there is a continuously emerging need for the development of novel materials that achieve multi-targeting of both cosmetic and therapeutic actions.
[0007]
[0008] Against this backdrop, the inventors have completed the present invention by developing a novel peptide that is easy to commercialize by cutting out and / or substituting some amino acids of a conventionally known peptide, thereby having effects of preventing skin aging, improving wrinkles, and enhancing skin elasticity, while also having effects of preventing hair loss and promoting hair growth, and possessing high hydrophilicity and excellent solubility in water.
[0009]
[0010] Accordingly, the object of the present invention is to provide a polypeptide having an amino acid sequence represented as (N-terminal) - X1X2X3X4X5D NIIDFLKD X6- (C-terminal) (Sequence No. 10), wherein X1 to X6 are each independently lysine (K) or arginine (R); X2, X3 and X5 are each alanine (A) or threonine (T); X4 is alanine (A), threonine (T), or aspartic acid (D); and X6 is aspartic acid (D) or asparagine (N).
[0011]
[0012] Another objective of the present invention is to provide a cosmetic composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, and a food composition comprising the polypeptide as an active ingredient.
[0013]
[0014] Another objective of the present invention is to provide a cosmetic composition and a food composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising the polypeptide.
[0015]
[0016] Another objective of the present invention is to provide a cosmetic composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, and a food composition essentially composed of the polypeptide.
[0017]
[0018] Another objective of the present invention is to provide a pharmaceutical composition for promoting hair growth or for preventing or treating hair loss, comprising the polypeptide as an active ingredient; a cosmetic composition and a food composition for promoting hair growth or for preventing or improving hair loss.
[0019]
[0020] Another objective of the present invention is to provide a pharmaceutical composition for promoting hair growth or for preventing or treating hair loss, comprising the polypeptide; a cosmetic composition for promoting hair growth or for preventing or improving hair loss; and a food composition.
[0021]
[0022] Another objective of the present invention is to provide a pharmaceutical composition for promoting hair growth or for preventing or treating hair loss, essentially composed of the polypeptide; a cosmetic composition and a food composition for promoting hair growth or for preventing or improving hair loss.
[0023]
[0024] Another objective of the present invention is to provide a use of the polypeptide for preparing cosmetic compositions and food compositions for preventing skin aging, improving wrinkles, enhancing skin flexibility, and enhancing skin elasticity.
[0025]
[0026] Another objective of the present invention is to provide a method for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising applying an effective amount of a cosmetic composition containing the polypeptide as an active ingredient to the skin of an individual in need thereof.
[0027]
[0028] Another objective of the present invention is to provide a method for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising administering an effective amount of a food composition containing the polypeptide as an active ingredient to an individual in need thereof.
[0029]
[0030] Another objective of the present invention is to provide a use of the polypeptide for preparing a pharmaceutical composition for promoting hair growth or for preventing or treating hair loss; and cosmetic and food compositions for promoting hair growth or for preventing or improving hair loss.
[0031]
[0032] Another objective of the present invention is to provide a method for promoting hair growth or preventing or treating hair loss, comprising administering an effective amount of a composition containing the above-mentioned polypeptide as an active ingredient to an individual in need thereof.
[0033]
[0034] Another objective of the present invention is to provide a method for promoting hair growth, or preventing or improving hair loss, comprising applying an effective amount of a cosmetic composition containing the polypeptide as an active ingredient to the skin of an individual in need.
[0035]
[0036] Another objective of the present invention is to provide a method for promoting hair growth, or preventing or improving hair loss, comprising administering an effective amount of a food composition containing the polypeptide as an active ingredient to an individual in need thereof.
[0037]
[0038] To achieve the above objectives, the present invention provides a polypeptide having an amino acid sequence represented as (N-terminal) - X1X2X3X4X5D NIIDFLKD X6- (C-terminal) (Sequence No. 10), wherein X1 to X6 are each independently lysine (K) or arginine (R); X2, X3, and X5 are each alanine (A) or threonine (T); X4 is alanine (A), threonine (T), or aspartic acid (D); and X6 is aspartic acid (D) or asparagine (N).
[0039]
[0040] To achieve another objective of the present invention, the present invention provides a cosmetic composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, and a food composition comprising the polypeptide as an active ingredient.
[0041]
[0042] To achieve another objective of the present invention, the present invention provides a cosmetic composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, and a food composition comprising the polypeptide.
[0043]
[0044] To achieve another objective of the present invention, the present invention provides a cosmetic composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, and a food composition, which are essentially composed of the polypeptide.
[0045]
[0046] To achieve another objective of the present invention, the present invention provides a pharmaceutical composition for promoting hair growth or preventing or treating hair loss, comprising the polypeptide as an active ingredient; a cosmetic composition and a food composition for promoting hair growth or preventing or improving hair loss.
[0047]
[0048] To achieve another objective of the present invention, the present invention provides a pharmaceutical composition for promoting hair growth or for preventing or treating hair loss, comprising the polypeptide; a cosmetic composition for promoting hair growth or for preventing or improving hair loss; and a food composition.
[0049]
[0050] To achieve another objective of the present invention, the present invention provides a pharmaceutical composition for promoting hair growth or for preventing or treating hair loss, essentially composed of the polypeptide; a cosmetic composition and a food composition for promoting hair growth or for preventing or improving hair loss.
[0051]
[0052] To achieve another objective of the present invention, the present invention provides a use of the polypeptide for preparing cosmetic compositions and food compositions for preventing skin aging, improving wrinkles, enhancing skin flexibility, and enhancing skin elasticity.
[0053]
[0054] To achieve another objective of the present invention, the present invention provides a method for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising applying an effective amount of a cosmetic composition containing the polypeptide as an active ingredient to the skin of an individual in need thereof.
[0055]
[0056] To achieve another objective of the present invention, the present invention provides a method for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising administering an effective amount of a food composition containing the polypeptide as an active ingredient to an individual in need thereof.
[0057]
[0058] To achieve another objective of the present invention, the present invention provides a use of the polypeptide for preparing a pharmaceutical composition for promoting hair growth or for preventing or treating hair loss; a cosmetic composition for promoting hair growth or for preventing or improving hair loss; and a food composition.
[0059]
[0060] To achieve another objective of the present invention, the present invention provides a method for promoting hair growth or preventing or treating hair loss, comprising administering an effective amount of a composition containing the above-mentioned polypeptide as an active ingredient to an individual in need thereof.
[0061]
[0062] To achieve another objective of the present invention, the present invention provides a method for promoting hair growth or preventing or improving hair loss, comprising applying an effective amount of a cosmetic composition containing the polypeptide as an active ingredient to the skin of an individual in need thereof.
[0063]
[0064] To achieve another objective of the present invention, the present invention provides a method for promoting hair growth or preventing or improving hair loss, comprising administering an effective amount of a food composition containing the polypeptide as an active ingredient to an individual in need thereof.
[0065]
[0066] The present invention will be described in detail below.
[0067]
[0068] In this specification, the term "comprising" is used with the same meaning as "including" or "characterized by," and does not exclude additional components or steps of the method that are not specifically mentioned in the composition or method according to the present invention. Furthermore, the term "consisting of" means excluding additional elements, steps, or components that are not separately described. The term "essentially consisting of" means that, within the scope of the composition or method, it may include, in addition to the described materials or steps, materials or steps that do not substantially affect the basic characteristics thereof.
[0069]
[0070] The present invention relates to a polypeptide having an amino acid sequence represented as (N-terminal) - X1X2X3X4X5D NIIDFLKD X6- (C-terminal) (Sequence No. 10), wherein
[0071] The above X1 to X6 are each independently,
[0072] X1 is lysine (K) or arginine (R);
[0073] X2, X3, and X5 are each alanine (A) or threonine (T);
[0074] X4 is alanine (A), threonine (T), or aspartic acid (D);
[0075] X6 is aspartic acid (D) or asparagine (N);
[0076] Provides phosphorus and polypeptides.
[0077] Preferably, the polypeptide according to the present invention may be a polypeptide characterized in that when X1 is lysine (K), X2 to X5 are alanine (A); or when X1 is arginine (R) and X2 and X3 are both alanine (A), X4 to X5 are one of alanine (A) - alanine (A), alanine (A) - threonine (T), and threonine (T) - threonine (T); or when X1 is arginine (R) and one of X2 and X3 is alanine (A), X4 to X5 are aspartic acid (D) - alanine (A). More preferably, the polypeptide according to the present invention may be a polypeptide characterized in having any one of the amino acid sequences of SEQ ID NOs 2 to 6, but is not limited thereto. More specifically, the amino acid sequences of polypeptides SEQ ID NOs 2 to 6 according to the present invention are as follows.
[0078] Sequence No. 2: KAAAADNIIDFLKDD
[0079] Sequence No. 3: RAAATDNIIDFLKDD
[0080] Sequence No. 4: RAATTDNIIDFLKDD
[0081] Sequence No. 5: RTADADNIIDFLKDN
[0082] Sequence No. 6: RATDADNIIDFLKDN
[0083]
[0084] In this specification, the terms "polypeptide," "peptide," and "protein" are used interchangeably and refer to polymers of amino acid residues as generally found in proteins in their natural state.
[0085] The single (or three) letters of amino acids used in this specification refer to the following amino acids in accordance with standard abbreviation rules in the field of biochemistry: A(Ala): Alanine; C(Cys): Cysteine; D(Asp): Aspartic acid; E(Glu): Glutamic acid; F(Phe): Phenylalanine; G(Gly): Glycine; H(His): Histidine; I(IIe): Isoleucine; K(Lys): Lysine; L(Leu): Leucine; M(Met): Methionine; N(Asn): Asparagine; O(Ply): Pyrrolicine; P(Pro): Proline; Q(Gln): Glutamine; R(Arg): Arginine; S(Ser): Serine; T(Thr): Threonine; U(Sec): Selenocysteine; V(Val): Valine; W(Trp): Tryptophan; Y(Tyr): Tyrosine.
[0086]
[0087] Meanwhile, the polypeptide according to the present invention may be produced (manufactured) by any suitable procedure known to those skilled in the art, namely genetic engineering methods, such as recombinant techniques. For example, a nucleic acid encoding the polypeptide or a functional equivalent thereof is produced according to conventional methods. The nucleic acid may be produced by PCR amplification using appropriate primers. Alternatively, a DNA sequence may be synthesized using standard methods known in the art, such as an automated DNA synthesizer (sold by Biosearch or Applied Biosystems). The produced nucleic acid is inserted into a vector containing one or more expression control sequences (e.g., promoters, enhancers, etc.) that are operatively linked to the nucleic acid to regulate its expression, and host cells are transformed with the recombinant expression vector formed therefrom. The resulting transformed cells are cultured under a medium and conditions suitable for the expression of the nucleic acid, and a substantially pure polypeptide expressed by the nucleic acid is recovered from the culture. The recovery may be performed using methods known in the art (e.g., chromatography). In the above, the term 'substantially pure polypeptide' means that the polypeptide according to the present invention does not substantially contain any other protein derived from a host cell.
[0088] For example, the polypeptide of the present invention can be prepared by direct peptide synthesis using a solid-phase technique. The solid-phase peptide synthesis (SPPS) method can initiate synthesis by attaching functional units called linkers to small porous beads to induce the continuation of peptide chains. Unlike the liquid-phase method, the peptide is covalently bonded to the beads to prevent it from being removed by a filtration process until it is cleaved by specific reactants such as TFA (trifluoroacetic acid). Synthesis is achieved through a repeated cycle (deprotection-wash-coupling-wash) of a protection process in which the N-terminal amine of the peptide attached to the solid phase binds to an N-protected amino acid unit, a deprotection process, and a coupling process in which the exposed amine group binds to a new amino acid. The above SPPS method can be performed in conjunction with microwave technology, and microwave technology can reduce the time required for coupling and deprotection in each cycle by applying heat during the peptide synthesis process. This thermal energy can prevent the expanding peptide chains from folding or aggregating and promote chemical bonding.
[0089] In addition, the peptide of the present invention can be produced by a liquid-phase peptide synthesis method, and specific methods thereof are referenced in the following literature: US Patent No. 5,516,891. In addition, the peptide of the present invention can be synthesized by various methods, such as a method of mixing the solid-phase synthesis method and the liquid-phase synthesis method, and the method of manufacture is not limited to the means described in this specification.
[0090] Protein synthesis can be performed using manual techniques or by automation. Automated synthesis can be achieved, for example, using an Applied Biosystems 431A peptide synthesizer (Perkin Elmer). Alternatively, various protein fragments can be chemically synthesized separately and combined using chemical methods to produce the target molecule.
[0091]
[0092] The range of polypeptides according to the present invention includes functional equivalents of the polypeptide of the present invention described above and salts thereof. The term "functional equivalent" refers to a peptide having at least 80%, preferably 90%, and more preferably 95% or more amino acid sequence homology (i.e., identity) with the polypeptide of the present invention described above, for example, having sequence homology of 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100%, and exhibiting substantially the same physiological activity as the polypeptide of the present invention. Here, the term "substantially" means exhibiting the entirety of a specific property or a property of nearly the same degree. Therefore, in this invention, "substantially homogeneous physiological activity" refers to activities that prevent skin aging, improve wrinkles, enhance skin flexibility, and improve skin elasticity through the effect of inducing fibroblast proliferation and / or promoting collagen synthesis; and activities that prevent hair loss and promote hair growth through the effect of inducing hair papilla cell proliferation.
[0093] In this specification, the term "functional equivalent" may be produced by adding, inserting, substituting (non-conservative or conservative substitution), deleting, or a combination thereof, a portion of the amino acid sequence of the polypeptide according to the present invention described above. The substitution of amino acids may preferably be a conservative substitution. Examples of conservative substitutions of naturally occurring amino acids are as follows: aliphatic amino acids (Gly, Ala, Pro), hydrophobic amino acids (Ile, Leu, Val), aromatic amino acids (Phe, Tyr, Trp), acidic amino acids (Asp, Glu), basic amino acids (His, Lys, Arg, Gln, Asn), and sulfur-containing amino acids (Cys, Met). Amino acid exchanges that do not alter the overall activity of the molecule are known in the art. Furthermore, the functional equivalent also includes a variant in which a portion of the amino acid is deleted from the amino acid sequence of the polypeptide of the present invention. The deletion or substitution of the amino acid is preferably located in a region that is not directly related to the physiological activity of the polypeptide provided by the present invention. In addition, it includes modified forms in which several amino acids are added to both ends or within the amino acid sequence of the polypeptide of the present invention. Furthermore, the scope of functional equivalents of the present invention includes polypeptides or protein derivatives in which a portion of the chemical structure of the polypeptide is modified while maintaining the basic framework of the polypeptide and its physiological activity. For example, this includes structural modifications to alter the stability, storage properties, volatility, or solubility of the polypeptide of the present invention, as well as fusion proteins created by fusing with other proteins while maintaining physiological activity.
[0094] In one embodiment, the polypeptide of the present invention may be modified by phosphorylation, sulfation, acrylation, glycosylation, methylation, farnesylation, etc., depending on the case.
[0095]
[0096] In this specification, the terms “polynucleotide” and “nucleic acid” refer to deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the form of a single-stranded or double-stranded form. Unless otherwise limited, known analogs of natural nucleotides that hybridize to nucleic acids in a manner similar to naturally occurring nucleotides are also included.
[0097] Meanwhile, a polynucleotide sequence encoding a polypeptide according to the present invention can be provided by operatively linking it to a vector capable of expressing it, thereby providing the polypeptide of the present invention described above.
[0098]
[0099] As mentioned above, collagen is a fibrous protein produced by fibroblasts in the dermis that makes up 70% of the dermis and is responsible for skin flexibility and elasticity. Therefore, if collagen synthesis decreases, skin elasticity and flexibility decline rapidly, leading to skin aging, sagging, and the formation of wrinkles. Conversely, when collagen synthesis is promoted within the skin, the components of the dermal matrix increase, resulting in effects such as wrinkle improvement, enhanced elasticity, and skin strengthening.
[0100] According to one embodiment of the present invention, the polypeptide according to the present invention has a fibroblast proliferation-inducing effect and a collagen synthesis-inducing effect (see Examples 3 and 4). Accordingly, the present invention provides a cosmetic composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising the polypeptide according to the present invention as an active ingredient; and a food composition.
[0101]
[0102] In this specification, the term "skin aging" has a broad meaning that includes both intrinsic aging, which is a natural aging phenomenon in which the structure and physiological functions of the skin undergo a continuous decline with age, and extrinsic aging, which is caused by various types of external factors such as sunlight, ultraviolet rays, drug side effects, stress, environmental factors, and injuries. Accordingly, in this specification, "prevention of skin aging" may be interpreted in a broad sense that includes inhibition, reduction, prevention, improvement, or prevention of skin aging conditions caused by various factors including intrinsic and extrinsic aging.
[0103]
[0104] In the present invention, the "cosmetic composition" may be prepared in any formulation conventionally manufactured in the art, and may be prepared in the form of an adjuvant for topical or systemic application conventionally used in the field of dermatology by containing a dermatologically acceptable medium or base in addition to the polypeptide according to the present invention.
[0105] In addition, the cosmetic composition according to the present invention may contain, in addition to the polypeptide according to the present invention, additionally auxiliary agents commonly used in the fields of cosmetic science or dermatology, such as fatty substances, organic solvents, solvents, thickeners and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, ionic or non-ionic emulsifiers, fillers, metal ion chelating agents and chelating agents, preservatives, vitamins, blockers, humectants, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles, or any other ingredients commonly used in cosmetics. And the above ingredients may be introduced in amounts commonly used in the field of dermatology.
[0106] Suitable formulations of the cosmetic composition may be provided in the form of, for example, a solution, gel, solid or paste anhydrous product, an emulsion obtained by dispersing an oil phase in an aqueous phase, a suspension, a microemulsion, a microcapsule, a microgranulocyte, or an ionic (liposome) or non-ionic vesicular dispersant, or in the form of a cream, skin, lotion, powder, ointment, spray, or conceal stick. Additionally, it may be prepared in the form of a foam or an aerosol composition further containing a compressed propellant. Products to which the cosmetic composition of the present invention may be added include, but are not limited to, formulations such as skin lotion, essence, nourishing essence, pack, soap, shampoo, cleansing foam, cleansing lotion, cleansing cream, body lotion, body cleanser, treatment, beauty fluid, emulsion, pressed powder, loose powder, and eyeshadow.
[0107] In addition, the cosmetic composition according to the present invention can be prepared as an injectable formulation for mesotherapy. The injectable formulation can be prepared according to techniques known in the art using a suitable dispersant or humectant and a suspending agent. For example, the polypeptide according to the present invention can be dissolved in saline solution or a buffer solution to be formulated for injection.
[0108] In addition, the cosmetic composition of the present invention may further include known substances having effects such as promoting collagen synthesis, promoting fibroblast proliferation, inhibiting / improving skin aging, moisturizing the skin, improving skin elasticity / flexibility, improving wrinkles, and strengthening skin function, in order to further enhance the effects of the present invention. Such substances may include, but are not limited to, retinoic acid, TGF (trans-forming growth factor), betulinic acid, cinnamic acids, hydrostilbene, vitamin A, vitamin E, vitamin C, red grape extract powder, etc. In addition, it may further contain other pharmaceutically, dermatologically, and / or cosmetically acceptable media or materials, such as substances that promote protein absorption into the skin, preservatives, hydrating agents, emulsification accelerators, and buffers.
[0109] The content of polypeptides contained in the cosmetic composition according to the present invention may be in the range of 0.0001 to 50 weight%, preferably 0.01 to 10 weight%, based on the total weight of the cosmetic composition, but is not limited thereto, and can be appropriately determined by a person skilled in the art by considering various factors such as the desired effect, degree of application, type of formulation, and stability of the peptides in the cosmetic composition.
[0110]
[0111] In the present invention, the "food composition" includes all forms such as functional food, nutritional supplement, health food, and food additives. The food composition of the above type can be manufactured in various forms according to conventional methods known in the art, and is not limited thereto, but may include processed meat products, fish products, tofu, jelly, porridge, noodles such as ramen or noodles, seasoning products such as soy sauce, soybean paste, red pepper paste, mixed sauce, sauces, snacks, dairy products such as fermented milk or cheese, pickled foods such as kimchi or pickled vegetables, fruits, vegetables, soy milk, fermented beverages, etc., and may be manufactured by adding the polypeptide according to the present invention during the process of manufacturing these foods.
[0112] In addition, the food composition of the present invention may include a health functional food. The term "health functional food" refers to a food manufactured and processed in the form of tablets, capsules, powders, granules, liquids, pills, etc., using raw materials or ingredients that have functional properties useful to the human body. Here, "functionality" means obtaining effects useful for health purposes, such as regulating nutrients or physiological actions regarding the structure and function of the human body. The health functional food of the present invention may be manufactured by methods commonly used in the art, and may be manufactured by adding raw materials and ingredients commonly added in the art during such manufacturing. Furthermore, the formulation of the health functional food may also be manufactured without restriction as long as it is a formulation recognized as a health functional food.
[0113] The food composition according to the present invention may additionally include one or more of the aforementioned known substances having effects such as promoting collagen synthesis, promoting fibroblast proliferation, inhibiting / improving skin aging, moisturizing the skin, enhancing skin elasticity / flexibility, improving wrinkles, and strengthening skin function, similar to the cosmetic composition described above.
[0114] In addition, the food composition of the present invention may contain various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonating agents used in carbonated beverages, etc. Furthermore, it may contain fruit pulp for the production of natural fruit juices, fruit juice beverages, and vegetable beverages. These ingredients may be used independently or in combination. Although the proportion of these additives is not critical, it is generally selected in the range of 0.01 to 0.3 parts by weight per 100 parts by weight of the food composition of the present invention, but is not limited thereto.
[0115] In addition, the food composition of the present invention may contain various flavoring agents or natural carbohydrates as additional ingredients, such as in conventional beverages. The carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As sweeteners, natural sweeteners such as taumatin and stevia extract, or synthetic sweeteners such as saccharin and aspartame may be used. The proportion of the natural carbohydrates may generally be about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 mL of the composition according to the present invention, but is not limited thereto.
[0116] The content of polypeptide contained in the food composition according to the present invention is not limited thereto, but is preferably 0.01 to 50 weight% of the finally produced food. The food composition of the present invention may be prepared in the form of a powder or a concentrate for use as a food additive.
[0117]
[0118] As mentioned above, dermal papilla cells are one of the constituent cells of the hair follicle and play an important role in the growth and maintenance of hair. Therefore, if the proliferation and activity of dermal papilla cells are reduced, the hair growth cycle may shorten and hair loss may be accelerated; conversely, by increasing the proliferation and survival rate of dermal papilla cells, the effects of promoting hair growth and preventing hair loss can be achieved.
[0119] According to one embodiment of the present invention, the polypeptide according to the present invention has an effect of inducing proliferation of hair papilla cells (see Example 5). Accordingly, the present invention provides a pharmaceutical composition for promoting hair growth or preventing or treating hair loss, comprising the polypeptide according to the present invention as an active ingredient; and a cosmetic composition for promoting hair growth or preventing or improving hair loss.
[0120]
[0121] In this specification, the term "hair" is interpreted to include, but is not limited to, head hair, hair, facial hair and / or body hair, broadly including, head hair, eyelashes, eyebrows, mustache, beard, ear hair, nose hair, chest hair, pubic hair, accessory hair, etc.
[0122] In this specification, the term "promoting hair growth" includes promoting the growth of hair already formed as well as the generation and growth of hair from hair follicles, and encompasses all of the following: promoting hair follicle formation, structural stabilization of hair follicles, facilitating the supply of nutrients and oxygen, inducing a new hair cycle and growth phase more quickly, extending the main growth phase (growth phase) of the hair cycle, increasing the hair growth rate and / or increasing the hair shaft width, thereby inducing or improving hair growth, but is not limited thereto.
[0123] In this specification, the terms "hair loss" or "alopecia" are used to encompass all symptoms of hair loss, regardless of the specific biological mechanism of hair loss. Accordingly, in this specification, "prevention or treatment of hair loss" and "prevention or improvement of hair loss" are used in a broad sense to collectively refer to the prevention, improvement, and treatment of hair loss.
[0124]
[0125] In the present invention, the "pharmaceutical composition" comprises a polypeptide according to the present invention as an active ingredient and may be formulated in a suitable form together with other pharmaceutically acceptable carriers, and may additionally contain excipients or diluents. The term "pharmaceutically acceptable" refers to a non-toxic composition that is physiologically acceptable and, when administered to humans, does not typically cause allergic reactions or similar reactions such as gastrointestinal disorders or dizziness.
[0126] Pharmaceutically acceptable carriers may additionally include, for example, carriers for oral administration or carriers for parenteral administration. Carriers for oral administration may include lactose, starch, cellulose derivatives, magnesium stearate, stearic acid, etc. Additionally, carriers for parenteral administration may include water, suitable oil, saline solution, aqueous glucose and glycol, etc., and may additionally include stabilizers and preservatives. Suitable stabilizers include antioxidants such as sodium bisulfite, sodium sulfite, or ascorbic acid. Suitable preservatives include benzalkonium chloride, methyl- or propyl-paraben, and chlorobutanol. In addition to the above components, the pharmaceutical composition of the present invention may additionally include lubricants, humectants, sweeteners, flavorings, emulsifiers, suspending agents, etc. Other pharmaceutically acceptable carriers and formulations may be referenced as known in the art.
[0127] In the present invention, the content of the composition is not significantly limited depending on the purpose or aspect of use, and may, for example, be 0.01 to 99 weight%, preferably 0.5 to 50 weight%, and more preferably 1 to 30 weight% based on the total weight of the composition. In addition, the pharmaceutical composition according to the present invention may further include additives such as pharmaceutically acceptable carriers, excipients, or diluents in addition to the active ingredient. The pharmaceutical composition of the present invention may contain 0.1 to 99.9 weight% of a polypeptide prepared by the method of the present invention and may contain 99.9% to 0.1 weight% of a carrier.
[0128] The pharmaceutical composition according to the present invention may be administered to mammals, including humans, by any method. For example, it may be administered orally or parenterally. Parenteral administration methods may include, but are not limited to, intravenous, intramuscular, intra-arterial, intramedullary, intradural, intracardiac, transdermal, subcutaneous, intraperitoneal, intranasal, intestinal, topical, sublingual, or rectal administration.
[0129]
[0130] The pharmaceutical composition of the present invention can be formulated into an oral or parenteral administration formulation according to the administration route described above.
[0131] In the case of formulations for oral administration, the composition of the present invention may be formulated using methods known in the art, such as powders, granules, tablets, pills, coated tablets, capsules, liquids, gels, syrups, slurries, and suspensions. For example, an oral formulation may be obtained by combining an active ingredient with a solid excipient, grinding the mixture, adding a suitable auxiliary agent, and then processing it into a granular mixture to obtain a tablet or a coated tablet. Examples of suitable excipients may include sugars such as lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, and maltitol; starches such as corn starch, wheat starch, rice starch, and potato starch; celluloses such as cellulose, methylcellulose, sodium carboxymethylcellulose, and hydroxypropylmethylcellulose; and fillers such as gelatin and polyvinylpyrrolidone. In addition, cross-linked polyvinylpyrrolidone, agar, alginic acid, or sodium alginate may be added as a disintegrant depending on the case. Furthermore, the pharmaceutical composition of the present invention may additionally include an anticoagulant, a lubricant, a wetting agent, a fragrance, an emulsifier, and a preservative.
[0132] In the case of formulations for parenteral administration, they may be formulated in the form of injections, creams, lotions, topical ointments, oils, moisturizers, gels, aerosols, and nasal inhalants by methods known in the art. These formulations are based on those generally known in the art of pharmaceutical chemistry.
[0133] In addition, the pharmaceutical composition according to the present invention may be administered alone or in combination with a known compound having an effect of preventing hair loss or promoting hair growth. Such combination therapy includes methods of including the components in the same composition or administering them simultaneously, and includes administering the polypeptide according to the present invention one or more times during a treatment process using one or more other hair loss treatment / hair growth promoters, but is not limited thereto.
[0134] Examples of known compounds having an effect of preventing hair loss or promoting hair growth that can be used in combination with the polypeptide of the present invention or a pharmaceutical composition comprising the polypeptide of the present invention include minoxidil, cromacalin, pinacidil, naminidil, diphenylcyclopropenone, tricomin, cyproterone acetate, danazol, flutamide; and 5-alpha reductase inhibitors selected from the group consisting of finasteride, turosteride, LY-191704, MK-306, and dutasteride. Compounds selected from the group consisting of striazines, benzopyrans, pyridinopyrans and thiane-1-oxides, or pharmaceutically acceptable salts thereof are included, but not limited thereto.
[0135]
[0136] In the case of the pharmaceutical composition according to the present invention, the total effective amount of the composition may be administered to a patient as a single dose, or administered via a fractionated treatment protocol involving multiple doses administered over a long period. The content of the active ingredient in the pharmaceutical composition according to the present invention may vary depending on the severity of the disease. Preferably, the preferred total dose of the pharmaceutical composition of the present invention may be about 0.01 μg to 10,000 mg per kg of patient body weight per day, most preferably 0.1 μg to 1,000 mg. However, since the effective dose for a patient is determined by considering various factors such as the formulation method, administration route, and number of treatments, as well as the patient's age, weight, health status, gender, severity of the disease, diet, and excretion rate, a person with ordinary knowledge in the art would be able to determine an appropriate effective dose of the composition of the present invention in light of these factors. As long as the pharmaceutical composition according to the present invention exhibits the effects of the present invention, its formulation, administration route, and administration method are not particularly limited.
[0137]
[0138] The present invention also provides cosmetic compositions and food compositions for promoting hair growth or preventing or improving hair loss, comprising a polypeptide according to the present invention as an active ingredient, and with respect to said cosmetic compositions and food compositions, the contents described above in cosmetic compositions and / or food compositions for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity may be applied as is.
[0139]
[0140] The present invention provides a use of the polypeptide for preparing cosmetic compositions and food compositions for preventing skin aging, improving wrinkles, enhancing skin flexibility, and enhancing skin elasticity.
[0141]
[0142] The present invention provides a method for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising applying an effective amount of a cosmetic composition containing the polypeptide as an active ingredient to the skin of an individual who requires it.
[0143]
[0144] The present invention provides a method for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising administering an effective amount of a food composition containing the polypeptide as an active ingredient to an individual in need thereof.
[0145]
[0146] The present invention provides a use of the polypeptide for preparing a pharmaceutical composition for promoting hair growth or for preventing or treating hair loss; a cosmetic composition for promoting hair growth or for preventing or improving hair loss; and a food composition.
[0147]
[0148] The present invention provides a method for promoting hair growth or preventing or treating hair loss, comprising administering an effective amount of a composition containing the above-mentioned polypeptide as an active ingredient to an individual in need thereof.
[0149]
[0150] The present invention provides a method for promoting hair growth, or preventing or improving hair loss, comprising applying an effective amount of a cosmetic composition containing the polypeptide as an active ingredient to the skin of an individual in need thereof.
[0151]
[0152] The present invention provides a method for promoting hair growth, or preventing or improving hair loss, comprising administering an effective amount of a food composition containing the polypeptide as an active ingredient to an individual in need thereof.
[0153]
[0154] As described above, the novel polypeptide according to the present invention simultaneously exhibits skin aging improvement and hair growth effects, and since it has excellent solubility in water based on its hydrophilicity, it is advantageous for formulation; therefore, it can be usefully utilized in the development of compositions for preventing skin aging, improving wrinkles, enhancing skin elasticity, preventing hair loss, and promoting hair growth.
[0155]
[0156] Figure 1 is a graph of the results of the Cell Counting Kit-8 Assay confirming whether the novel polypeptide produced in the first stage induces fibroblast proliferation.
[0157] Figure 2 is a graph of the Cell Counting Kit-8 Assay results confirming whether the novel polypeptide according to the present invention induces fibroblast proliferation.
[0158] Figure 3 is a graph of the results of a Procollagen Type I ELISA confirming whether the novel polypeptide according to the present invention induces collagen synthesis.
[0159] Figure 4 is a graph of the Cell Counting Kit-8 Assay results confirming whether the novel polypeptide according to the present invention induces dermal papilla cell proliferation.
[0160] Figure 5 is a graph of the Cell Counting Kit-8 Assay results confirming the cytotoxicity of the novel polypeptide according to the present invention.
[0161]
[0162] The present invention will be described in detail below.
[0163] However, the following examples are merely illustrative of the present invention, and the content of the present invention is not limited to the following examples.
[0164]
[0165] Example 1. Primary production and screening of a novel polypeptide
[0166] First, based on the polypeptide fragment (Neopep S1) confirmed in the inventor's previous research (Registered Patents No. 10-2017796 and No. 10-2336341) to have effects such as promoting hair growth, preventing hair loss, preventing skin aging, improving wrinkles, and enhancing skin elasticity, we intended to produce a polypeptide fragment having hydrophilicity and excellent solubility in water to facilitate product commercialization while maintaining those effects.
[0167] To this end, various polypeptide fragments were prepared by cutting, inserting, and / or substituting some amino acids of existing polypeptide fragments, and their PI, hydrophilicity, and solubility in water were measured, respectively. PI and hydrophilicity were analyzed using a Peptide Calculator (Bachem, Swiss) based on the sequence of each polypeptide, and solubility was determined by adding 1 mg of polypeptide to 1 ml of triple-distilled water, vortexing for 1 minute, incubating at room temperature for 1 hour, and then visually checking for crystallization of the peptide.
[0168]
[0169] Table 1 below shows the results.
[0170]
[0171] Polypeptide No. Amino Acid Sequence PI Hydrophilicity DW Solubility (mg / ml) Neopep S1 (Sequence No. 1) KGAEADQIIEYLKQQ534621 (Sequence No. 2) KAAAADNIIDFLKDD855554 (Sequence No. 7) RLDNKAADADNIIDF26371>5 (Sequence No. 8) KRLANKAADADNIID26371>18 (Sequence No. 9) RLDNKAAAADNIIDF89731>
[0172]
[0173] Among the above polypeptides, polypeptides No. 4 and No. 5, which are close to hydrophobic, were excluded, and polypeptides No. 1 and No. 18 were tested below to determine whether they retained the effects of the existing polypeptides.
[0174] First, human foreskin fibroblasts Hs68 (human fibroblast, 3,000 cells / well) were cultured in a 96-well plate in 10% serum-containing DMEM medium for 12 hours, and then cultured again in serum-free medium for about 3 hours. After that, 2.5 µg / ml of each polypeptide (Neopep S1, No.1, and No.18) was added to the DMEM medium and cultured for 48 hours. Subsequently, 10 µl of CCK-8 solution (Dojindo Molecular Technologies, Japan) was added to each well of the medium, and the absorbance was analyzed at 450 nm using a microplate reader according to the manufacturer's instructions.
[0175] As a result, as can be seen in Figure 1, polypeptide No. 1 showed a much higher level of fibroblast proliferation induction effect compared to the positive control (positive control, Neopep S1 treatment group), but polypeptide No. 18 showed a significantly lower effect.
[0176]
[0177] Example 2. Secondary production of a novel polypeptide
[0178] Based on the results of Example 1 above, in order to further improve polypeptide No. 1, additional amino acid modifications were applied to newly synthesize the following four polypeptides. Table 2 below shows information regarding the sequence, PI, degree of hydrophilicity, and solubility in water of the five novel polypeptide fragments.
[0179] Polypeptide No. (Sequence No.) Amino Acid Sequence PI Hydrophilicity DW Solubility (mg / ml) 1 (Sequence No. 2) KAAAADNIIDFLKDD 3.85 0.55 0.51 - 1 (Sequence No. 3) RAAATDNIIDFLKDD 3.85 0.56 0.51 - 2 (Sequence No. 4) RAAATTDNIIDFLKDD 3.85 0.571 > 1 - 3 (Sequence No. 5) RTADADNIIDFLKDN 3.85 0.611 > 1 - 4 (Sequence No. 6) RATDADNIIDFLKDN 3.85 0.611 >
[0180] Based on the above results, the following experiments were conducted using No. 1-2, No. 1-3, and No. 1-4 peptides, which have excellent water solubility (1>) and high hydrophilicity among the five polypeptides mentioned above.
[0181]
[0182] Example 3. Fibroblast proliferation-inducing effect of the novel polypeptide
[0183] To confirm the fibroblast proliferation-inducing effect of the polypeptide prepared in Example 1 above, the CCK-8 assay (Cell Counting Kit-8 assay) of Dojindo Molecular Technologies (Japan) was performed according to the manufacturer's method.
[0184] First, human foreskin fibroblasts Hs68 (human fibroblast, 3,000 cells / well) were cultured in 96-well plates in 10% serum-containing DMEM medium for 12 hours, and then cultured again in serum-free medium for about 3 hours. After that, 1 µg / ml, 5 µg / ml, or 25 µg / ml of each polypeptide was added to the DMEM medium and cultured for 48 hours.
[0185] Afterwards, 10 µl of CCK-8 solution (Dojindo Molecular Technologies, Japan) was added to each well of the above medium, and the absorbance was analyzed at 450 nm using a microplate reader according to the manufacturer's instructions.
[0186] As a result, as can be seen in Figure 2, all tested peptides exhibited superior fibroblast proliferation-inducing effects compared to the control group (con). In particular, the group administered 5 ug / ml of peptide No. 1-4 (sequence number 6) showed the most superior effect, exhibiting a fibroblast proliferation-inducing effect of over 30% compared to the control group.
[0187]
[0188] Example 4. Collagen synthesis-inducing effect of a novel polypeptide
[0189] To confirm the collagen synthesis-inducing effect of the novel polypeptides, human foreskin fibroblasts Hs68 (human fibroblast, 3,000 cells / well) were cultured for 12 hours in 10% serum-containing DMEM medium in a 96-well plate, and then cultured again for about 3 hours in serum-free medium. Subsequently, 1 µg / ml, 5 µg / ml, or 25 µg / ml of each novel polypeptide was added to the DMEM embryos, and the cells were cultured for 24 hours. Afterward, the medium was recovered and centrifuged at 1,000g for 10 minutes, and the secreted collagen was detected using a Procollagen Type I ELISA kit (Takara, Japan) according to the manufacturer's instructions.
[0190] As a result, as can be seen in Figure 3, all tested peptides exhibited a collagen synthesis-inducing effect similar to that of the positive control group treated with TGF-b. In particular, the No. 1-4 polypeptide treatment group showed a superior collagen synthesis-inducing effect compared to the TGF-b treatment group.
[0191]
[0192] Example 5. Effect of inducing proliferation of human follicle dermal papilla cells
[0193] To confirm the hair growth-inducing and anti-hair loss effects of the novel polypeptide, HFDPC (Human follicle dermal papilla cells) were cultured in 96-well plates at a concentration of 3,000 cells / well in 10% serum-containing DMEM medium for 12 hours, followed by incubation in serum-free medium for approximately 3 hours. Subsequently, 1 µg / ml, 5 µg / ml, or 25 µg / ml of each polypeptide was added to the DMEM medium and cultured for 48 hours. Afterward, 10 µl of CCK-8 solution (Dojindo Molecular Technologies, Japan) was added to each well of the medium, and the absorbance was analyzed at 450 nm using a microplate reader according to the manufacturer's instructions.
[0194] As a result, as can be seen in Figure 4, all tested peptides exhibited excellent dermal papilla cell proliferation-inducing effects compared to the control group (con). In particular, all peptides showed excellent dermal papilla cell proliferation effects of over 50% in the 1 µg / ml treatment group.
[0195]
[0196] Example 6. Confirmation of cytotoxicity
[0197] To confirm the cytotoxicity of the novel polypeptide, the CCK-8 assay (Cell Counting Kit-8 assay) from Dojindo Molecular Technologies (Japan) was performed according to the manufacturer's instructions. First, normal epithelial cells (Vero, monkey kidney epithelial cells, 5,000 cells / well) were cultured in 96-well plates in 10% serum-containing DMEM medium for 12 hours, followed by incubation in serum-free medium for approximately 3 hours. Subsequently, 1 µg / ml, 5 µg / ml, or 25 µg / ml of each novel protein variant was added to the DMEM medium, and the cells were cultured for 48 hours. Afterward, 10 µl of CCK-8 solution (Dojindo Molecular Technologies, Japan) was added to each well of the medium, and the absorbance was analyzed at 450 nm using a microplate reader according to the manufacturer's instructions.
[0198] As a result, although the viability of epithelial cells decreased slightly in the case of peptides No. 1-3 and No. 1-4, all experimental groups showed a survival rate of over 90%, demonstrating stable results with almost no cytotoxicity.
[0199]
[0200] From the above results, it was confirmed that the novel polypeptide according to the present invention has the effects of inducing fibroblast proliferation (Example 3) and collagen synthesis (Example 4), thereby having the effects of preventing skin aging, improving wrinkles, enhancing skin flexibility, and enhancing skin elasticity, and at the same time also has the effect of inducing hair papilla cell proliferation (Example 5), thereby having the effects of preventing hair loss and / or promoting hair growth.
[0201]
[0202] As described above, the novel polypeptide according to the present invention simultaneously exhibits skin aging improvement and hair growth effects. Furthermore, based on its hydrophilicity, it possesses excellent solubility in water, which is advantageous for formulation. Therefore, it can be usefully utilized in the development of compositions for preventing skin aging, improving wrinkles, enhancing skin elasticity, preventing hair loss, and promoting hair growth, thus having high potential for industrial application.
Claims
1. A polypeptide having an amino acid sequence represented as (N-terminus) - X1X2X3X4X5D NIIDFLKD X6- (C-terminus) (Sequence No. 10), The above X1 to X6 are each independently, X1 is lysine (K) or arginine (R); X2, X3, and X5 are each alanine (A) or threonine (T); X4 is alanine (A), threonine (T), or aspartic acid (D); X6 is aspartic acid (D) or asparagine (N); am.
2. A polypeptide according to claim 1, wherein when X1 is lysine (K), X2 to X5 are alanine (A).
3. A polypeptide according to claim 1, wherein X1 is arginine (R) and X2 and X3 are both alanine (A), and X4-X5 are any one of alanine (A)-alanine (A), alanine (A)-threonine (T), and threonine (T)-threonine (T).
4. A polypeptide according to claim 1, wherein X1 is arginine (R) and either X2 or X3 is alanine (A), and X4-X5 are aspartic acid (D) - alanine (A).
5. The polypeptide according to claim 1, wherein the peptide has any one of the amino acid sequences of SEQ ID NO. 2 to SEQ ID NO.
6.
6. A cosmetic composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising a polypeptide of any one of claims 1 to 5 as an active ingredient.
7. A food composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising a polypeptide of any one of claims 1 to 5 as an active ingredient.
8. A pharmaceutical composition for promoting hair growth, or for preventing or treating hair loss, comprising a polypeptide of any one of claims 1 to 5 as an active ingredient.
9. In claim 8, the composition comprises a 5-alpha reductase inhibitor selected from the group consisting of minoxidil, cromakalin, pinacidil, naminidil, diphenylcyclopropenone, tricomin, cyproterone acetate, danazol, flutamide; finasteride, turosteride, LY-191704, MK-306, and dutasteride; A pharmaceutical composition characterized by further comprising a compound selected from the group consisting of striazines, benzopyrans, pyridinopyrans, and thiane-1-oxides, or a pharmaceutically acceptable salt thereof.
10. A cosmetic composition for promoting hair growth, or for preventing or improving hair loss, comprising a polypeptide of any one of claims 1 to 5 as an active ingredient.
11. A food composition for promoting hair growth, or for preventing or improving hair loss, comprising a polypeptide of any one of claims 1 to 5 as an active ingredient.
12. Use of the polypeptide of any one of claims 1 to 5 for preparing a cosmetic composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity.
13. A method for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising applying an effective amount of a cosmetic composition containing a polypeptide of any one of claims 1 to 5 as an active ingredient to the skin of an individual in need thereof.
14. Use of the polypeptide of any one of claims 1 to 5 for preparing a food composition for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity.
15. A method for preventing skin aging, improving wrinkles, enhancing skin flexibility, or enhancing skin elasticity, comprising administering an effective amount of a food composition containing a polypeptide of any one of claims 1 to 5 as an active ingredient to an individual in need thereof.
16. Use of the polypeptide of any one of claims 1 to 5 for preparing a pharmaceutical composition for promoting hair growth, or for preventing or treating hair loss.
17. A method for promoting hair growth, or preventing or treating hair loss, comprising administering an effective amount of a composition containing a polypeptide of any one of claims 1 to 5 as an active ingredient to an individual in need thereof.
18. Use of the polypeptide of any one of claims 1 to 5 for preparing a cosmetic composition for promoting hair growth, or for preventing or improving hair loss.
19. A method for promoting hair growth, or preventing or improving hair loss, comprising applying an effective amount of a cosmetic composition containing a polypeptide of any one of claims 1 to 5 as an active ingredient to the skin of an individual in need thereof.
20. Use of the polypeptide of any one of claims 1 to 5 for preparing a food composition for promoting hair growth, or for preventing or improving hair loss.
21. A method for promoting hair growth, or preventing or improving hair loss, comprising administering an effective amount of a food composition containing a polypeptide of any one of claims 1 to 5 as an active ingredient to an individual in need thereof.
